Suppr超能文献

威斯康星大学溶液与赛而西奥溶液对胰腺的保存作用

Pancreas preservation with the University of Wisconsin versus Celsior solutions.

作者信息

Manrique A, Jiménez C, Herrero M L, Meneu J C, Abradelo M, Moreno A, González E, Hernández E, Morales J M, Andrés A, Cortina J, Moreno E

机构信息

Servicio de Cirugía General, Ap Digestivo y Trasplante de Organos Abdominales, Hospital Universitario Doce de Octubre, Madrid, Spain.

出版信息

Transplant Proc. 2006 Oct;38(8):2582-4. doi: 10.1016/j.transproceed.2006.08.058.

Abstract

INTRODUCTION

The use of Celsior solution for organ preservation has not been thoroughly studied in pancreas transplantation. The aim of this study was to compare University of Wisconsin and Celsior solutions for preservation of pancreas grafts.

PATIENTS AND METHODS

From March 1995 to December 2005, 72 patients with type 1 diabetes underwent pancreas transplantation. There were 42 men and 30 women, with a mean age at transplantation of 38.1 +/- 7.5 years (range: 27 to 55 years), and a mean duration of diabetes of 22.5 +/- 6.6 years. Recipients were classified into two groups according to the preservation solution: (A) Celsior (n = 28, 38.9%) and (B) Wisconsin (n = 44, 61.1%).

RESULTS

The donor and recipient characteristics were similar in both groups. There were five cases of venous thrombosis in the Wisconsin group and two in the Celsior group (P = NS). The venous drainage technique in the former group was portocaval in 19 patients and portoiliac in 25; in the Celsior group, portocaval in 23 patients and portoiliac in five (P = .001). Enteric drainage was used in 19 patients from the Celsior group and 17 patients from the Wisconsin group (P = .01). Actuarial 2-year graft survival was 74.6% in the Wisconsin group and 77.4% in the Celsior group (P = NS).

CONCLUSIONS

No differences were observed in venous thrombosis between the two groups. The lower rate of venous thrombosis with the portocaval technique was related to the type of venous drainage rather than the type of preservation solution. Celsior solution may be considered as good as Wisconsin solution for pancreas transplantation.

摘要

引言

在胰腺移植中,尚未对赛而斯欧(Celsior)溶液用于器官保存进行全面研究。本研究的目的是比较威斯康星(Wisconsin)溶液和赛而斯欧溶液对胰腺移植物的保存效果。

患者与方法

1995年3月至2005年12月,72例1型糖尿病患者接受了胰腺移植。其中男性42例,女性30例,移植时的平均年龄为38.1±7.5岁(范围:27至55岁),糖尿病平均病程为22.5±6.6年。根据保存溶液将受者分为两组:(A)赛而斯欧组(n = 28,38.9%)和(B)威斯康星组(n = 44,61.1%)。

结果

两组的供者和受者特征相似。威斯康星组有5例静脉血栓形成,赛而斯欧组有2例(P = 无显著性差异)。前一组的静脉引流技术中,19例为门静脉-腔静脉吻合,25例为门静脉-髂静脉吻合;赛而斯欧组中,23例为门静脉-腔静脉吻合,5例为门静脉-髂静脉吻合(P = 0.001)。赛而斯欧组19例患者和威斯康星组17例患者采用了肠道引流(P = 0.01)。威斯康星组2年移植物精算生存率为74.6%,赛而斯欧组为77.4%(P = 无显著性差异)。

结论

两组在静脉血栓形成方面未观察到差异。门静脉-腔静脉技术静脉血栓形成率较低与静脉引流类型有关,而非保存溶液类型。对于胰腺移植,赛而斯欧溶液可被认为与威斯康星溶液一样好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验